Project description
Advancing nanomedicine for precision diagnosis and treatment
Nanotechnology has found numerous applications in the biomedical sector in drug delivery, diagnostics and treatment monitoring. Nanomaterials offer precise and targeted solutions, improving therapies and enabling earlier disease detection with remarkable accuracy. Funded by the Marie Skłodowska-Curie Actions programme, the LungCare project will leverage nanotechnology towards the development of nanovaccines and inhalable therapeutics against Pseudomonas aeruginosa lung infections. Researchers will also develop diagnostic sensors for lung cancer analysis along with portable tests for early tuberculosis detection. The project is a collaborative effort with EU and associated country partners, fostering knowledge exchange and sustaining high-tier research.
Objective
Nanotechnology concepts have integrated into almost all aspects of current research and the present research area is recognised to be one of nanoscience. Nanomaterials are promising materials to develop new technologies in every branch of science and technology. This is also true when it comes to the biomedical field, where nanotechnology in the form of nanomedicine has a great potential to overcome some of the current limitations using conventional analytical and therapeutic approaches. The focal point of the LungCare project is to turn nanotechnological potentials into tangible outcomes with benefits for patients and the society at large. The philosophy behind LungCare is to provide improvement to the treatment of Pseudomonas aeruginosa (PA) infections via nanovaccines and inhalable therapeutics. It focuses also on the pending question for early and accurate diagnostics of tuberculosis (TB) and lung cancer via the development of sensitive point of care testing devices. In case of lung cancer, sensor development will be accompanied by quantitative image analysis to increase diagnostic accuracy and improve our understanding of the disease characteristics. The LungCare project aims at training of the next generation of students in this rapidly advancing field at the interface between chemistry-physics-biology-medicine and to up-date and improve the know-how of senior researchers and PIs in important parts of nanomedicine such as clinical assay development, state-of the art of organoid developments to limit in vivo testing via and the implementation of artificial intelligent in diagnostics. The different intersectoral secondments to 2 European countries (France, Austria), 2 associated countries (Turkey, Ukraine) and one associated partner (Argentina) will strengthen nanomedicine on the EU level, will encourage knowledge gain and will insure preserving high level research activities under the EU umbrella.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences medical biotechnology nanomedicine
- medical and health sciences clinical medicine pneumology tuberculosis
- medical and health sciences clinical medicine oncology
- engineering and technology nanotechnology nano-materials
- humanities philosophy, ethics and religion philosophy
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA)
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-TMA-MSCA-SE - HORIZON TMA MSCA Staff Exchanges
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-MSCA-2022-SE-01
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
75794 PARIS
France
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.